Louisiana and Gilead Sciences are working on a deal that would change how the state pays for expensive hepatitis C drugs, with the goal of eliminating the disease in that state.
NPR’s Alison Kodjak and The Center for Public Integrity have been looking at all the ways the drug industry tries to keep Medicaid money flowing. Here they examine how the drug industry’s massive lobbying effort in every state has blocked efforts to co…
Drug companies have infiltrated nearly every part of the process that determines how their drugs will be covered by Medicaid, an investigation by NPR and the Center for Public Integrity finds.
Treatment costs for the immunotherapy can run to more than $1 million. Some state Medicaid programs aren’t paying for the treatment, and Medicare’s complicated payment rates have hospitals worried.
Without scrutiny, insurers and data brokers are predicting your health costs based on public data about things like race, marital status, your TV consumption and even if you buy plus-size clothing.
The vast amount of data held in electronic medical records and insurance bills contains bits that could be useful in refining the use of approved for drugs. But how to find it?
The vast amount of data held in electronic medical records and insurance bills contains bits that could be useful in refining the use of approved for drugs. But how to find it?
Abortion rights advocates are concerned that a conservative-leaning Supreme Court might reverse or substantially erode Roe v. Wade. Under that scenario, states could have free reign to restrict the procedure.
A Senate investigation into prescription opioids in Missouri finds that pharmaceutical wholesalers had different standards for reporting suspicious orders to the Drug Enforcement Administration.